The global preclinical
in vivo imaging solutions market is foreseen to grow at 5.9%, from USD 580.4 Million
in 2021 to USD 918.1 Million in 2029. Technological advancements in the field
of molecular imaging, increasing market demand for noninvasive small-animal
imaging techniques, growing number of public-private initiatives and funding to
support preclinical researches are the factors driving the growth of the global
preclinical in vivo imaging solutions market. However, strict regulations
governing preclinical research, significant installation and operational costs
associated with preclinical imaging modalities is anticipated to restrain the
market growth for the estimated period.
Market Definition
What is Preclinical In
Vivo Imaging Solutions?
Preclinical
imaging is the visualization of living animals for research purposes, such as
drug development. Imaging modalities have long been crucial to the researcher
in observing changes, either at the organ, tissue, cell, or molecular level, in
animals responding to physiological or environmental changes.
Research Scope
The report
provides market value for base year 2021 and a yearly forecast from 2022 to
2029 in terms of revenue (USD Million). Market for each segment is present on
North America, Europe, Asia Pacific, Latin America and Middle East & Africa
as well as regional basis for the above-mentioned forecast period.
Key industry
dynamics, regulatory scenario, major material dynamics and Preclinical In Vivo
Imaging Solutions future markets are analyzed to understand their impact on
demand for the forecast period. Growth rates have been estimated using
correlation, regression and time-series analysis.
Market Overview
Preclinical In
Vivo Imaging Solutions Market report also provide a thorough understanding of
the cutting-edge competitive analysis of the emerging market trends along with
the drivers, restraints, challenges, and opportunities in the Preclinical In
Vivo Imaging Solutions Market to offer worthwhile insights and current scenario
for making right decision. The report covers the prominent players in the
market with detailed SWOT analysis, financial overview, and key developments of
the products/services from the past three years. Moreover, the report also
offers a 360º outlook of the market through the competitive landscape of the
global industry player and helps the companies to garner Preclinical In Vivo
Imaging Solutions Market revenue by understanding the strategic growth
approaches.
Preclinical In
Vivo Imaging Solutions Market study by “Zettabyte Analytics” provides details
about the market dynamics affecting the market, Market scope, Market
segmentation and overlays shadow upon the leading market players highlighting
the favorable competitive landscape and trends prevailing over the years.
Market Segmentation
For the purpose
of this report, the global Preclinical In Vivo Imaging Solutions Market is
segmented on the basis of Modality Type, Reagent and region:
Modality Type
|
Micro-CT
|
Micro-MRI
|
Micro-Ultrasound
|
Nuclear Imaging Systems
|
|
Micro-PET Systems
|
|
Micro-Spect Systems
|
|
Trimodality (Spect/PET/CT) Systems
|
Optical Imaging Systems
|
|
Bioluminescence/Fluorescence Imaging Systems
|
|
Standalone Fluorescence Imaging Systems
|
|
(Optical + X-Ray)/(Optical + CT) Systems
|
Other Imaging Systems
|
|
|
Reagent
|
Preclinical CT Contrast Agents
|
Preclinical MRI Contrast Agents
|
Preclinical Nuclear Imaging Reagents
|
|
Preclinical PET Tracers
|
|
Preclinical Spect Probes
|
Preclinical Optical Imaging Reagents
|
|
Bioluminescent Imaging Reagents
|
|
Fluorescent Imaging Reagents
|
Preclinical Ultrasound Contrast Agents
|
Modality Type Outlook:
On the basis of
Modality Type, the market is segmented into Micro-CT, Micro-MRI,
Micro-Ultrasound, Nuclear Imaging Systems, Optical Imaging Systems, Other
Imaging Systems. Further, Nuclear Imaging Systems is segmented into Micro-PET
Systems, Micro-Spect Systems, Trimodality (Spect/PET/CT) Systems. Further,
Optical Imaging Systems is segmented into Bioluminescence/Fluorescence Imaging
Systems, Standalone Fluorescence Imaging Systems, (Optical + X-Ray)/(Optical +
CT) Systems.
Figure 1 - Preclinical In Vivo Imaging Solutions
Market, By Modality Type (Market Size And Forecast By Value - USD Million, 2021
& 2029)